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The tandem b-zipper protein–protein binding interface involves an intrinsically disordered protein
(IDP) binding two or more globular domains through b-sheet-augmentation in a modular fashion,
and represents a paradigm in IDP-mediated protein–protein interactions. While characterised tan-
dem b-zippers are rare, known examples are associated with diverse biological processes. A combi-
nation of their advantages (binding speciﬁcity and the ability to generate high afﬁnity binding sites
by linking multiple lower afﬁnity motifs) and the prevalence of both tandem domains and IDPs
points to the existence of many more b-zippers in nature. The characterisation of these interactions
has greatly enhanced the understanding of the biological systems involved but given their apparent
tolerance to mutation, detecting other tandem b-zipper interactions using bioinformatics may be
challenging.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction the cell. While disordered regions in general appear to evolve moreFor several decades following the determination of the ﬁrst pro-
tein structures, it was generally considered that proteins had to
have a stable fold to be functional. However, over the last 10–
15 years [1–3] this ‘‘structure–function paradigm’’ has been well
and truly dispelled and ‘‘unstructural biology’’ [4] is now a major
area of interest in protein science. Bioinformatics predictions sug-
gest that up to 35% of prokaryotic and 45% of eukaryotic proteins
contain signiﬁcant regions of intrinsic disorder but with large vari-
ations between organisms within these groups [5]. Intrinsic disor-
der appears to be particularly enriched in proteins involved in
differentiation, transcription, spermatogenesis, DNA condensation
and the cell cycle [6]. Experimental observations clearly show that
many proteins can be both disordered and functional [7] and that
disorder is not just an in vitro observed phenomenon but can exist
within the cell despite macromolecular crowding [8,9]. The preva-
lence of disorder suggests that it provides signiﬁcant advantages
and these include functional plasticity [1,10,11] and ﬁnely-tuned
[12] and efﬁcient [13,14] protein–protein interactions. Disorder,
due to its role in regulation, and facilitation of different conforma-
tional states and transitions between them, has been described as a
playing a ‘‘molecular rheostat’’ [15] or ‘‘administrative’’ [16] role inrapidly than ordered regions [17], binding to cognate ligands is of-
ten mediated through short linear motifs (3–10 residues) that can
be recognised by a higher level of conservation than surrounding
residues in the primary sequence [18]. Many disordered regions
undergo a disorder-to-order transition on binding which can pro-
vide high speciﬁcity combined with moderate afﬁnity due to the
unfavourable entropy involved when folding and binding are cou-
pled [17].
This review focuses on a type of protein–protein interaction
mediated by intrinsically disordered proteins (IDPs) that illustrates
many of the characteristics mentioned above. In the tandem b-zip-
per interaction [19,20] tandemly-arrayed short linear motifs from
an IDP bind to a second protein through b-sheet-augmentation on
consecutive globular domains. The interaction is tuneable (through
variation in the number of motifs and domains involved) and efﬁ-
cient in the case of the IDP as the interface represents a higher per-
centage of the accessible surface area than for the folded protein
(i.e., interface residues predominate in the IDP). We describe the
discovery of tandem b-zippers using biophysical and structural
methods, compare the existing well-deﬁned tandem b-zipper com-
plexes, discuss the advantages conferred by this type of interaction,
and the challenges of identifying new tandem b-zippers.
2. Discovery of two tandem b-zipper interactions
b-Strand addition is a common mode of binding and b-sheet
augmentation (along with strand insertion and fold complementa-
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2003 all the examples had been addition of a strand (or strand-
swap) to a single domain. In 2003 and 2004 [19,20,22] examples
were reported of ‘‘tandem b-zippers’’ where b-sheet augmentation
occurs on sequential domains through a single peptide containing
multiple short linear motifs (Fig. 1).
2.1. Fibronectin-binding proteins
Fibronectin (Fn)-binding proteins (FnBPs) from Staphylococcus
aureus and Streptococcus pyogenes are cell-wall attached proteins
that mediate bacterial invasion of eukaryotic cells [23,24]. Rather
than targeting integrins directly (as some pathogens do [25]) these
bacteria target integrins indirectly by using the human plasma and
extracellular matrix protein Fn as a bridge to integrins on the
eukaryotic cell surface. For example, FnBPA from S. aureus [26]
and SfbI from S. pyogenes [27] contain multiple binding sites for
the N-terminal domain (NTD) of Fn which contains ﬁve small tan-
demly arrayed b-sandwich domains known as Fn type I domains
(1–5F1). The presence of multiple high afﬁnity Fn-binding sites re-
sults in efﬁcient invasion of host cells [28]. The ﬁrst tandem b-zip-
per was reported in the interaction of a short peptide from FnBB
from Streptococcus dysgalactiae (which is homologous to SfbI) with
1F12F1 from the NTD of Fn [29] (Fig. 1A). The bacterial peptide,
which corresponds to the C-terminus of the Fn-binding region in
intact FnBB, was shown to bind 1F12F1 in an anti-parallel manner
[19]; two short motifs in FnBB added an extra anti-parallel strand
to the triple-stranded b-sheet of sequential domains. The work re-
vealed the approximate motif-length required for F1 binding and,
with earlier work [29,30], revealed short consensus motifs for
binding to speciﬁc F1 modules in the NTD. These studies led to
the dissection of the Fn-binding regions of SfbI [27] and FnBPA
[26] into multiple Fn-binding repeats (FnBRs) (Fig. 2A) and to the
demonstration that tandem b-zipper interactions formed by bacte-
rial proteins can form across four [31] and even ﬁve [27,32] F1
modules (Fig. 2B). The 2F1 and 4F1 modules of Fn share signiﬁcant
sequence similarity [33] and this is reﬂected in the 2F1- and 4F1-
binding motifs in bacterial proteins. For example, the conserved
hydroxyl-containing side-chain near the C-terminus of the 2F1-
and 4F1-binding motifs (Fig. 2A and B) forms a hydrogen bond with
homologous backbone atoms of the corresponding modules. The
3F1 and 5F1-binding regions are less well-conserved; the only
highly conserved residue, a glycine in the 3F1-binding motif binds
adjacent to a bulky tryptophan side-chain in the edge strand of 3F1
(Fig. 2). Although individual short linear motifs bind with low
afﬁnity and show some ability to bind other F1 modules, the tan-
dem arrangement of multiple F1 motifs in the correct order to bind
consecutive modules in the NTD results in high afﬁnity and speciﬁc
binding [27] (Fig. 2C). A similar mechanism of Fn-binding was dis-
covered in BBK32, a surface protein of the Lyme disease-causing
spirochete Borrelia burgdorferi [34] but BBK32 only contains a sin-
gle Fn-binding site.
2.2. LIM-binding domains
LIM (lin-11/Isl-1/Mec3) domains are zinc ﬁngers that coordinate
two zinc ions that are essential for folding, and act exclusively to
mediate protein–protein interactions [35]. LIM only (LMO) and
LIM homeodomain (LIMHD) proteins are related families of meta-
zoan proteins that play key roles in tissue development, including
cell speciﬁcation and the regulation of proliferation and differenti-
ation. These proteins contain two closely spaced LIM domains at or
near their N-terminus. LMO proteins contain little other sequence,
whereas LIM homeodomain proteins contain a central homeodo-
main that binds DNA and an often uncharacterised C-terminal do-
main. The LMO/LIMHD family of proteins is predominantlynuclear, and involved in gene regulation at the level of transcrip-
tion, either binding DNA directly (as in the case of LIMHD proteins)
or through binding to transcription factors (LMO proteins). The
tandem LIM domains from all LMO and LIMHD proteins bind to
LDB1 (LIM domain binding protein 1) through the 30-residue
LIM interaction domain (LID). LDB1 is an essential cofactor for
the LMO/LIMHD family; its ability to self-associate [36,37] facili-
tates formation of long range interactions within chromatin
[38,39]. Initially the structures of the single LIM domain complexes
LMO2LIM1–LDB1LID and LMO4–LDB1LID were determined by NMR
spectroscopy [22], shortly followed by the X-ray structure determi-
nation of LMO4–LDB1LID [20] (Fig. 1B). The resulting structures
showed that the molecules bind in a head-to-tail fashion, forming
a very modular tandem b-zipper structure in which LDB1LID forms
a series of short b-strands that augment existing b-hairpins in each
of the zinc-binding modules from both LIM domains.
Additional tandem LIM–LDB1 complexes for LMO2, and the
LIMHD protein LHX3 have since been characterised, all of which
have a very similar overall structure [40,41]. A combination of
structural and mutagenic studies suggests the tandem b-zipper
for these interactions comprises two 8–10 residue linear motifs
(rather than four shorter motifs; Fig. 1B) interspersed by a ‘‘spacer’’
of 9 residues. The spacer appears to be relatively plastic, adopting
differing conformations or being poorly deﬁned in different com-
plexes, and having little or no apparent contribution to the ener-
getics of binding [20,40,42].
Essentially identical complexes are formed between the LIM do-
mains of LHX3 and a LID-like LHX3-binding domain (LBD) from the
intrinsically disordered C-terminal region of ISL1 [40], and the
equivalent LHX4/ISL2 complex [43] (Fig. 3A). Interactions between
these LHX and ISL proteins are required for motor neuron speciﬁ-
cation [44–46]. Although there is little sequence identity between
ISL1LBD and LDB1LID, both proteins bind LHX3 in an identical fash-
ion, apart from a shorter spacer in Isl1LBD (Fig. 3).
An additional tandem b-zipper interaction was recently de-
scribed between the cytoskeleton-associated LIM-domain protein
TES (which is not related to LMO/LIMHD proteins) and the actin-
related protein ARP7A, which colocalise to the acrosome (an orga-
nelle found in spermatozoa) [47]. Of the three tandemly-arrayed
LIM domains near the C-terminus of TES, LIM2 and LIM3 bind to
a LID-like motif within the intrinsically disordered N-terminal do-
main of ARP7A (ARP7A27–49). The structure of an ARP7A/TES/MENA
complex shows that ARP7A/TES bind with the same basic topology
as tandem LIM–LDB1/ISL complexes (Fig. 3A). The main difference
between these tandem b-zippers is that whereas the spacer resi-
dues in LDB1/ISL LIM binding-domains do not contribute to bind-
ing, those in the considerably shorter ARP7A spacer appear to be
most important for binding, as suggested by extensive contacts
at the ARP7A/TES interface and far-Western analysis of an
ARP7A27–49 peptide array [47].
All of these complexes feature the burial of a hydrophobic side-
chain from the peptide between the zinc-binding modules of each
LIM domain, but only in some complexes does this side-chain bur-
ial appear to be important for binding. For example, LDB1I322 is a
key residue for binding several LMO/LIMHD proteins [40], but
mutation of ARP7AA30 to all other residues has little affect on bind-
ing in the peptide array assay [47].
Small-angle X-ray scattering data are consistent with limited
ﬂexibility at the hinge/spacer for some of the LHX-LDB1/ISL pep-
tide complexes, and the identity of the binding peptide appears
to inﬂuence the relative orientation between the LIM domains
(Fig. 3C). For example, the LHX3/LHX4–ISL2 complexes are more
compact than LHX3–LDB1/ISL1 complexes, which may in turn
inﬂuence formation of higher order complexes [43,48]. The very
short spacer in ARP7A likely contributes to the relatively compact
structure observed for TES/ARP7A (although to date there is no
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Fig. 1. Tandem b-zippers. (A) Top: Solution structure of 1–2F1 (magenta) in complex with Fn-binding motifs from FnBB (yellow; pdb code 1O9A). Bottom: Schematic of
binding topology with Fn in grey and FnBB motifs in yellow; b strands are shown as arrows. (B) Top: Crystal structure of an LMO4 (blue)–LDB1 (orange/white) complex (pdb
code 1RUT). Zinc ions are shown as grey spheres and zinc-coordinating side-chains as grey sticks. The position of the hinge (the hinge point between the tandem LIM
domains; blue spheres) and spacer (the region between the two linear motifs; white) are indicated. Bottom: Schematic of binding topology with LMO4 in grey and LDB1 in
orange. b-Strands are shown as arrows, a-helices are shown as cylinders. For these complexes secondary structure features tend to be short, but are of variable length and
may not be well deﬁned.
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was suggested that for LMO2/LDB1 ﬂexibility at the hinge/spacer
is important for formation of higher order transcriptional com-
plexes [41]. Mutations of the residue in LMO2 that was predicted
to confer ﬂexibility (LMO2F88) inhibited the activity of LMO2 in a
cell expansion assay in zebraﬁsh [41]. A more prosaic explanation
is that F88 contributes to structure [49] and mutation of this resi-
due simply destabilised or affected the fold of LMO2.
3. Technical challenges and methodological approaches
In studying both the bacterial FnBPs and the LIM-binding pro-
teins, a key challenge was identiﬁcation of the minimal regions
that reﬂect the native interaction; in all cases a combination of
molecular, biophysical and structural techniques was required. A
series of deletion constructs for each set of partners was madeand tested for binding. For the globular protein it was relatively
straightforward to identify the domains. Although short b-strands
can sometimes be predicted within the IDPs using bioinformatic
approaches, it was much harder to identify the boundaries of the
linear motifs based on the sequence of the IDP. Thus, a systematic
approach involving sequence analysis (informed by the structures
of the complexes) was carried out and the binding of different
sized fragments tested. The binding assay depended on the system
under study. For the LMO/LIMHD proteins, yeast two-hybrid anal-
ysis proved particularly useful because LIM domains from these
proteins tend to be insoluble and highly aggregation-prone
in vitro. Other two-hybrid systems, co-immunoprecipitation and
pulldown experiments can also be used as binding assays (e.g.
[47]), but where possible it is preferable to use methods that pro-
vide more precise information about binding such as isothermal
titration calorimetry (ITC) and nuclear magnetic resonance
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Fig. 2. Modular binding in Fn–FnBPA complexes. (A) The highest afﬁnity Fn-binding repeats from FnBPA (S. aureus) [26] and SfbI (S. pyogenes) [27] highlighting conserved
motifs in the 2F1- and 4F1-binding regions and the single conserved glycine residue in the 3F1-binding region. (B) Based on structures of staphylococcal (2F13F1-binding and
4F15F1-binding) and streptococcal (1F12F1-binding) FnBP peptides (grey) in complex with their cognate Fn domains (cyan), and afﬁnities of the interactions, the most C-
terminal Fn-binding repeat in the streptococcal protein SfbI (SfbI-5) can form a tandem b-zipper across ﬁve F1 modules [31] (pdb codes 2RKY, 2RKZ and 1O9A). Residues
highlighted in the alignment are shown as grey sticks and are boxed and the tryptophan residue in 3F1 (mentioned in the text) is shown as cyan sticks and indicated by a black
arrow. (C) Bacterial FnBPs contain multiple regions each containing sequential motifs that bind 2–5F1 (2F1-binding, light grey; 3F1-binding, mid grey; 4F1-binding, dark grey;
5F1-binding, black). The streptococcal Fn-binding proteins SfbI and FnBB contain an additional N-terminal motif that binds 1F1 (white). Selection of different N- and C-termini
for the bacterial peptides used in NMR spectroscopy and ITC experiments leads to large differences in measured afﬁnities for Fn module pairs and the NTD. The predicted
physiologically relevant binding site boundaries are indicated in solid lines while peptides of similar length but with incorrect boundaries (which result in weaker binding)
are shown as dotted lines.
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Fig. 3. Comparison of LIM–peptide tandem b-zippers. (A) Overlays of LIM–peptide tandem b-zippers. LMO4/LDB1 (dark blue/yellow; pdb code 1RUT); TES/ARP7A (cyan/
magenta; pdb code 2XQN); LHX3/ISL1 (mid-blue/orange; pdb code 2RGT). As the relative orientations of the LIM domains in the structures vary, the structures are separately
overlaid over the LIM1 and LIM2 domains. Residues from ARP7A, LDB1 and ISL1 that are buried between each LIM domain are shown as sticks. (B) Structure-based sequence
alignment of LIM-binding domains from LDB1, ISL1, ISL2 and ARP7A are shown. Residues in the spacer are shown for reference but have no structural alignment, highlighted
residues are buried between the zinc-binding modules in each LIM domain. (C) Schematics of LIM–peptide complexes indicating spacer length in the peptides and relative
orientation of the LIM domains. Colouring is as in A.
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perturbation assays to detect interactions over a wide range of
afﬁnities [50], and to provide residue speciﬁc and structural infor-
mation, make this a powerful technique for studying protein–pro-
tein interactions.
Structure determinations were also challenging. The problem of
insoluble and/or aggregating LIM domains from the LMO/LIMHD
proteins was addressed by engineering ‘‘tethered complexes’’ in
which the LIM domains were fused to LDB1LID via a ﬂexible linker
[51]. It is the head-to-tail arrangement of the subunits in the tan-
dem b-zipper (i.e. the N-terminus of one partner lies close to the C-
terminus of the other and vice versa) that makes this approach so
successful. In most cases it is possible to swap the positions of the
partners in the tethered protein construct, although the stability of
the different arrangements can vary; it is even possible to generate
circularised complexes with a linker at both ends using intein
chemistry [52]. By engineering a speciﬁc protease site into the lin-
ker, and comparing the NMR spectra of these complexes before and
after proteolytic cleavage, it was shown that the tethered and ‘‘cut’’
complexes have the same structure [20,22,40]. Although it is
impossible to measure binding afﬁnities by standard biophysical
methods if one or both of the interacting proteins is not well-be-
haved in solution, cut/tethered complexes can be used in homolo-
gous competition ELISAs to gain estimates of binding afﬁnities
[20,40,42], and to gauge the relative stabilities of intact tethered
complexes [40,43].
In the case of the FnBPs, most of the problems arose from the
difﬁculty of identifying the correct binding site boundaries in a
bacterial protein that contains multiple intrinsically-disordered
binding sites for Fn. That is, the Fn-binding proteins contain multi-
ple, consecutive binding sites for the NTD of Fn and each binding
site contains consecutive short linear motifs that bind to the indi-
vidual domains within the NTD (Fig. 2). If incorrect sequence
boundaries were chosen for either the full binding sites or the short
linear motifs, the motifs for binding to 2F1, 3F1, 4F1 and 5F1 were
either incomplete or in the wrong sequence to bind the cognate re-
gion of the NTD (Fig. 2C). Correct identiﬁcation of NTD-binding site
boundaries led to a decrease in the dissociation constant (Kd) for
the interaction from micromolar to nanomolar [27]. Here the com-
bination of NMR spectroscopy and ITC was particularly useful. In
the initial absence of a structure of a complex, NMR studies
showed that on binding of a bacterial peptide to 1F12F1 both do-
mains were affected and that residues in the C-terminal strand of
the triple stranded b-sheet in both modules underwent the largest
changes in chemical shift. By producing shorter peptides that con-
tained individual F1-binding motifs, it was also straightforward to
show (despite the weak interaction) that the C-terminal half of the
peptide bound 1F1 and not 2F1, conﬁrming the antiparallel orienta-
tion of binding [29]. ITC was used to compare the afﬁnities of the
interactions of motifs that bound module pairs (e.g. 1F12F1,
4F15F1) or larger fragments (1–5F1) (for Kds in the micromolar to
nanomolar range; Fig. 2C). ITC was also readily employed to deter-
mine the effects on binding of mutation of conserved residues (see
below; [53,54]). Both NMR spectroscopy [19] and X-ray crystallog-
raphy [31,54] have been used to solve the structures of bacterial
peptide/F1 module pair complexes.
4. Common themes in tandem b-zipper interactions
4.1. Binding afﬁnity
A key characteristic of the tandem b-zipper motif is the gener-
ation of higher afﬁnity interactions by linking a series of short lin-
ear binding motifs of much lower afﬁnity. This is particularly
evident in the Fn/Fn-binding protein complexes, where up to ﬁve
modules can be bound by the IDP in interactions with Kds below1 nM. The interdomain interfaces are large given the length of
the intrinsically-disordered region. The enthalpy of the interac-
tions observed in ITC experiments are correspondingly high [27],
which is presumably required to balance the entropically unfa-
vourable disorder–order transitions. These are most obviously
manifest in the gain of secondary structure in the IDPs on binding,
and might also arise from restricted motion of the globular do-
mains relative to one another [43,48,49]. In many designed inter-
action systems (i.e. where high afﬁnity has been selected in vitro
through combinatorial selection approaches such as phage display)
high afﬁnity is achieved at the expense of a loss of binding speciﬁc-
ity that can result in off target effects (e.g. artiﬁcial zinc ﬁnger nuc-
leases [55,56]). The tandem b-zipper, however, appears to be a
mechanism through which nature has evolved highly speciﬁc, high
afﬁnity protein–protein interactions.
4.2. Tuneability
In addition to generating a high afﬁnity interaction, the use of
multiple motifs gives rise to a very tuneable system. In the context
of the Fn/bacterial protein interaction, if it is assumed that individ-
ual Fn-binding repeats have evolved from a single repeat, there are
some highly conserved motifs while other parts of the sequence,
which nonetheless adopt a b-strand structure on binding, are
poorly conserved (Fig. 2). Individual motifs with very low intrinsic
binding afﬁnities [27] are tolerated within a multiple motif region,
conceivably allowing the evolution of very tailored interactions.
For example, in mammals LDB1 can bind to the 16 different mem-
bers of the LMO/LIMHD family, but not to other LIM domain pro-
teins. Although all of these proteins appear to require both LIM
domains for high afﬁnity binding, the relative contribution of each
domain varies (e.g. [22,36,40,42]). As the LMO/LIMHD proteins re-
quire LDB1 for biological activity, competition for this cofactor pro-
tein is likely to provide a mechanism for generating cell-speciﬁc
transcriptional complexes, and within the family members for
which LDB1-binding afﬁnities have been measured, there is a hier-
archy of interaction afﬁnities (LMO4 > LMO2 > LHX3 > ISL1)[40,42].
A different aspect of tuneability within the tandem b-zipper inter-
action is evident in the streptococcal protein SfbI. This protein con-
tains an additional motif, which lies N-terminal to one of the NTD-
binding regions and binds to the 8F19F1-module pair of the gelatin-
binding domain (GBD) of Fn [32]; binding to 8F1 is through an
extension of the tandem b-zipper that forms along 2–5F1. This
GBD-binding motif increases the afﬁnity of the bacterial Fn-bind-
ing repeat for Fn and adds functionality by signiﬁcantly increasing
the efﬁciency of invasion of eukaryotic cells [57].
4.3. Speciﬁcity
Conceptually, the formation of backbone–backbone hydrogen
bonds between polypeptide binding partners, which is the deﬁning
feature of b-augmentation, is a non-speciﬁc binding event. This is
often accompanied by large hydrophobic contacts between side-
chains, which are also relatively non-speciﬁc binding events. Thus,
it might be expected that tandem b-zippers, being a series of bind-
ing modules with these features, should exhibit non-speciﬁc bind-
ing or slippage (where a single repeat could binding multiple
modules, or bind in different registers). Fn–FnBP interactions can
give rise to low afﬁnity cross-reactive binding events when single
F1-binding motifs are tested ([27] as expected due to the similarity
in the sequences of their target F1 modules), but speciﬁcity is in-
creased when multiple motifs are arrayed as is the case in vivo.
For LMO/LIMHD–peptide interactions no interactions have been
detected through mismatched linear motifs/LIM domains (e.g.
[20,40,42]). In both systems, electrostatic interactions (sometimes
with non-edge strand residues), apparently speciﬁc hydrophobic
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tides between the ZN modules within the LIM domains) and steric
effects (Fig. 2) appear to be largely responsible for maintaining the
register and speciﬁcity of binding.
The large size of the binding interfaces, and the overall toler-
ance to small numbers of mutations suggests that tandem b-zipper
interactions may lack binding hotspots that are observed in the
interactions of globular protein–protein interactions [53], such as
the case of the Fn–bacterial FnBP interactions [54]. However, in
the LMO/LIMHD–LDB1 system there is a binding hotspot centred
on LDB1I322 (which is buried in the interface between the two
Zn-coordinating modules of the LIM1 domain), but the equivalent
residue in LDB1 that binds the LIM2 domain does not appear to be
important for binding, and a larger proportion of residues contrib-
ute to binding at that interface. This phenomenon of one small and
one large binding hotspot on successive modules may contribute
to the lack of cross-reactivity in this system. The TES/ARP7A sys-
tem appears to have a similar arrangement (ARP7AA41 is a key
binding residue, but ARP7AA30 is not), although the contribution
of the spacer residues is very important for binding in that system
[47].
4.4. Edge strand protection
Free edge strands of b-sheets are usually protected by a variety
of mechanisms to prevent strand–strand aggregation [58]. Such
protection mechanisms include short strands, charged side-chains,
proline residues and b-bulges. Thus the existence of b-strand aug-
mentation in protein–protein interactions implies that the edge
strands of the folded protein are rather poorly protected. Struc-A B
C
Q
R3
Fig. 4. Tandem b-zipper binding results in only subtle changes in the edge-strands of the
pdb code 2RKZ) and absence (dark blue; pdb code 2CG7) of an FnBPA peptide. (B) CPK v
(bottom) of FnBPA (grey). Positively-charged residues (dark blue) that might be burie
negatively-charged (red) or polar (pink) bacterial peptide residues. The tryptophan resid
mentioned in the text, are also shown. (C) LIM3 from TES in the absence (orange; pdb cod
strands from TES are numbered and shown as sticks with oxygen atoms in red and nitrtures of 2F13F1 in the presence and absence of an FnBPA peptide
[31,59] (Fig. 4A and B) show that the edge strands are rather short
(4 residues in length); they contain charged residues but only at
the extremities of the augmented strand and these charged side-
chains either remain solvent exposed on zipper binding or are in
close proximity to oppositely-charged residues on the added
strand. There is little conformational change in the F1 modules
on bacterial peptide binding Fig. 4). Intriguingly, the edge-strand
of 3F1 appears to be sterically protected by a tryptophan side-chain
as suggested by the presence of a highly conserved glycine in the
corresponding position in 3F1-binding peptides ([31,54]). In the
TESLIM3 domain in the presence and absence of RNP7A a glutamine
side-chain folds over the b-strand in the absence of RNP7A, which
may also provide limited edge strand protection; here again there
is little conformational change in the augmented sheet induced on
binding (Fig. 4C).
In vivo, edge strands may be effectively protected by forming an
interaction either within the same molecule or with other mole-
cules. The NTD of Fn has been implicated in intra-molecular inter-
actions with 3F3 in the central region of Fn [60]. This might provide
protection for the edge strands of one or more of the F1 modules
but, as yet, it is not clear which part of the F1 modules form this
interaction. SfbI binds to both NTD and 8F19F1 in the gelatin-bind-
ing domain (GBD) of Fn, and appears to mimic a physiological in-
ter-molecular interaction of Fn with collagen which might also
protect Fn edge strands in vivo. The collagen peptide binds to 8F1
in the GBD in a b-zipper interaction [61] and an SfbI peptide can
disrupt the interaction [32]. In the case of the LMO and LIM-
homeodomain proteins, poor edge strand protection and exposure
of extensive hydrophobic surfaces likely led to the problems373
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globular modules. (A) Overlay of the 2F13F1 modules from Fn in the presence (cyan;
iew of binding surfaces of the F1 modules (cyan) in the absence (top) and presence
d on strand augmentation either remain solvent-exposed or are in proximity to
ue in 3F1 (yellow) and conserved glycine in the bacterial peptide (green), that are
e 2IYB) and presence (purple; pdb code 2XQN) of ARP7A. The side-chains of the edge
ogen atoms in blue; the ARP7A binding site is indicated by a black line.
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cell many of these proteins are invariably bound by a partner pro-
tein, and formation of new partnerships requires some sort of
cofactor exchange mechanism. However, ISL1 and ISL2 contain
both LIM and LIM-binding domains [40,43], and might form in-
tra-molecular LIM–peptide interactions.
5. More tandem b-zipper structures? Future challenges and
unanswered questions
It has been predicted that 40% of IDPs contain repeat regions
[62], and up to 11% of metazoan proteins contain tandem do-
mains [63]. Several domain types (e.g. Ig, PDZ, PHD, MYND and
FYVE [21,35]) have their b-sheets augmented in single domain-
containing protein complexes, thus many more proteins might
interact through, as yet undetected, tandem b-zippers. Based on
the levels of sequence variation we have observed between pep-
tides binding to the same protein (containing either Fn or LIM do-
mains, Figs. 2A and 3B), it will be very challenging to detect
completely novel tandem b-zippers using bioinformatics ap-
proaches at the organism and inter-organism levels. For the near
future, these types of interactions are more likely to be detected
in low throughput studies of protein–protein interactions. How-
ever, molecular interaction data with improved standardisation
within searchable databases is becoming more available [64] and
algorithms for detection of potential interaction motifs within IDPs
are improving [65]. In addition, NMR chemical shift data for disor-
dered peptides can be analysed to reveal secondary structure pro-
pensity, which may predict regions that form strands on complex
formation [54]. Thus, it should soon be possible to detect candidate
IDPs that might interact with a protein containing tandemly ar-
rayed b-sheet domains. Further analysis, for example to detect
poorly protected edge strands, could result in a manageable subset
of interactions for experimental validation using the biophysical
and structural approaches discussed above.
Several of the complexes described herein are associated with
disease, and it would be of interest to disrupt or inhibit the tandem
b-zipper interfaces. At this stage no speciﬁc tandem b-zipper inhib-
itors have been well characterised, although an intrabody (intra-
cellular single chain antibody) and peptide aptamer inhibitors of
LMO2 have been generated [66,67], which may block LMO2–
LDB1 interactions. Given the plasticity intrinsic to IDPs, and the
lack of identiﬁable hotspot residues in the FnBP IDPs (see above),
it may be more prudent to target the globular domains involved
in the tandem b-zippers complexes, either through peptidomimet-
ic approaches to recapitulate b-strand formation, or small molecule
inhibitors of protein–protein interactions.
6. Conclusions
The Fn-binding protein and LIM domain protein interactions
were challenging to detect and characterize, but the resulting
structures of the complexes and studies of binding speciﬁcity have
transformed our understanding of the biological systems involved.
It is hoped that this review, in highlighting this unusual mecha-
nism of protein–protein recognition, the experimental challenges
and the approaches used to study it, may lead to improved detec-
tion and a better understanding of the wide range of biological sys-
tems in which such interactions are likely to be found.Acknowledgements
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